Figure 5.

VP16 counteracts telomere anchoring in cis. (A) Telomeres used in the VP16 targeting assay. (B) Tel6R^tr position was monitored for G1 and S phase cells (GA-1917) expressing a lexA or a lexA-VP16 fusion as indicated. (C) As (B), but for Tel8L^nat (GA-1986), which lacks lexA sites. (D) As (B), but positions of Tel6R^nat (GA-3453) and Tel6R^tr (GA-3052) were monitored in tel1Δ G1-phase cells. Zone 1 percentages are compared and asterisks represent values that are not significantly different from random.